Toggle navigation
Kaspar Rufibach
Home
Publications
Textbook
Software
Talks
Teaching & supervision
Working groups
Implications of the ICH E9 estimand addendum on how we develop, run, and analyze clinical trials
Date
Oct 16, 2019
11:25 — 11:45
Event
Clinical Trials Europe (invited talk)
Location
Basel, Switzerland
Links
Slides
←
Before going BIG - seize opportunities for small data: use of multistate models to improve decision-making and effect quantification in clinical trials
Use of multistate models to jointly model progression-free and overall survival and improve decision-making in clinical trials
→
×
Cite